ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1219

Periodontal Disease Is Associated with Rheumatoid Arthritis but Its Severity Is Not Correlated with Rheumatoid Arthritis Disease Activity

In Ah Choi1, Jin-Hee Kim2, Kyung Hwa Kim2, Hye Won Kim3, Myeong Jae Yoon1, Bon Seung Ku4, Hyejin Oh3, Joo Youn Lee5, Eun Young Lee1, Eun Bong Lee6, Yong-Moo Lee2 and Young Wook Song7, 1Department of Internal Medicine, School of Medicine, Seoul National University, Seoul, South Korea, 2Department of Periodontology, School of Dentistry, Seoul National University, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Central Hospital, Ulsan, South Korea, 5Department of molecular medicine and biophamaceutical sciences,Seoul National University, Seoul, South Korea, 6Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 7Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: The prevalence of periodontal disease is known to be increased in patients with rheumatoid arthritis (RA) compared to the general population. We investigated whether severity of periodontal disease is associated with RA and correlated with RA disease activity, ACPA status or treatment medication.

Methods: We conducted a cross-sectional study comparing 295 RA patients and 88 non-arthritis controls. In RA patients, serum RF, anti-CCP antibody, CRP and ESR were measured. Clinical parameters including tender joint count (TJC), swollen joint count (SJC), DAS28 and presence of erosive changes in X- ray were evaluated at the time point obtaining samples. In all subjects, a number of teeth (0~28, 3rd molars excluded) was checked. Subjects who had 15 or more teeth were evaluated for dental exam and checked for P. gingivalis antibody. Plaque index (PI) was evaluated as a marker of dental hygiene and gingival index (GI), probing pocket depth (PPD), bleeding on probing (BOP) and clinical attachment loss (CAL) were evaluated as index of periodontitis. Periodontitis was defined as mild (CAL 1~2 mm), moderate (CAL 3~4 mm) and severe (CAL ≥ 5mm) by American Academy of Periodontology 2004 Classification.

Results: The mean number of teeth (±SD) in 295 RA patients and 88 controls were 23.4 ± 6.2 vs. 25.8 ± 2.9, respectively (p= 0.001). Among 290 RA patients, 28 patients (8.8%) had less than 15 teeth and 3 patients had ongoing dental care, both were excluded from the dental exam. Mean PI in 264 RA patients and 88 controls were 0.84 ± 0.49 and 0.70 ± 0.34 (p=0.014), mean GI 0.51 ± 0.43 vs. 0.15 ± 0.18 (p < 0.001), mean PPD 2.0 ± 0.4 vs. 1.7 ± 0.2 (p < 0.001), mean BOP 20.1 ± 15.4 vs. 12.3 ± 11.0 (p < 0.001) and mean CAL 3.2 ± 0.8 vs. 2.9 ± 0.5 (p < 0.001). The prevalence of moderate or severe periodontitis was significantly higher in RA patients compared to controls (63.6% vs. 33.3%, p< 0.001). Mean P. gingivalis antibody level (±SD) was higher in RA compared to control (34227 ± 55100 vs. 18341 ± 13147 unit/mL, p< 0.001). In RA patients, presence of dry mouth was associated with higher BOP (p= 0.022). Disease duration was associated with higher GI (r2= 0.044, p= 0.002) and BOP (r2= 0.022, p= 0.016). The patients with high positive anti-CCP antibody (≥ 15 IU/mL) showed higher GI than patients with negative (< 5 IU/mL, p= 0.002) or low positive (≥ 5 and < 15 IU/mL, p=0.046) anti-CCP antibody. There was no significant association between severity of periodontitis and RA disease activity markers (TJC, SJC, ESR, CRP, DAS28), presence of bone erosion, rheumatoid factor or use of steroid or biologic agents.

Conclusion: Patients with RA had more severe periodontal index than controls. Severity of periodontitis was associated with the presence of dry mouth, anti-CCP antibody and RA disease duration but not with disease activity.


Disclosure:

I. A. Choi,
None;

J. H. Kim,
None;

K. H. Kim,
None;

H. W. Kim,
None;

M. J. Yoon,
None;

B. S. Ku,
None;

H. Oh,
None;

J. Y. Lee,
None;

E. Y. Lee,
None;

E. B. Lee,
None;

Y. M. Lee,
None;

Y. W. Song,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/periodontal-disease-is-associated-with-rheumatoid-arthritis-but-its-severity-is-not-correlated-with-rheumatoid-arthritis-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology